Assistant Professor
McGill University
Dr. Antonios Douros received his Medical Degree in 2009 and his Doctorate Degree (Dr. med.) in 2012, and was trained in Clinical Pharmacology from 2012 to 2016 at Charité – Universitätsmedizin Berlin in Berlin, Germany. He completed a post-doctoral fellowship in Pharmacoepidemiology from 2016 to 2018 at the Department of Epidemiology, Biostatistics and Occupational Health at McGill University in Montreal, Canada. He then joined the Department of Medicine at McGill University as an Assistant Professor in 2019.
Dr. Douros studies the effectiveness and safety of commonly prescribed medications in vulnerable populations, including patients with liver disease, older adults, as well as patients subjected to polypharmacy and at risk of drug-drug interactions. Given the underrepresentation of such populations in randomized controlled trials, this research program provides much needed information regarding the benefit-risk profile of approved medications. For the implementation of this program, Dr. Douros applies his experience with observational studies using large electronic healthcare databases and his knowledge with respect to the distinct pharmacologic features of vulnerable populations.
Dr. Douros is a member of the Canadian Venous Thromboembolism and Outcomes Research (CanVECTOR) Network and the Canadian Network for Observational Drug Effect Studies (CNODES). He has received personal salary support awards from the German Research Foundation and the Fonds de recherche du Québec - Santé, and also research grants from the Canadian Institutes of Health Research.
Tuesday, July 12, 2022
2:45 PM – 3:00 PM